[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Iqvia Holdings Inc (IQV)

Iqvia Holdings Inc (IQV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 30,410,850
  • Shares Outstanding, K 166,900
  • Annual Sales, $ 16,310 M
  • Annual Income, $ 1,360 M
  • EBIT $ 3,367 M
  • EBITDA $ 4,534 M
  • 60-Month Beta 1.18
  • Price/Sales 1.85
  • Price/Cash Flow 10.14
  • Price/Book 4.84

Options Overview Details

View History
  • Implied Volatility 42.96% (+3.08%)
  • Historical Volatility 50.73%
  • IV Percentile 78%
  • IV Rank 59.73%
  • IV High 54.24% on 04/22/26
  • IV Low 26.22% on 11/26/25
  • Expected Move (DTE 18) 13.52 (7.42%)
  • Put/Call Vol Ratio 0.32
  • Today's Volume 208
  • Volume Avg (30-Day) 577
  • Put/Call OI Ratio 1.05
  • Today's Open Interest 8,545
  • Open Int (30-Day) 9,193
  • Expected Range 168.70 to 195.73

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 22 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $2.74
  • Number of Estimates 6
  • High Estimate $2.80
  • Low Estimate $2.71
  • Prior Year $2.53
  • Growth Rate Est. (year over year) +8.30%

Price Performance

See More
Period Period Low Period High Performance
1-Month
154.50 +17.94%
on 04/30/26
185.28 -1.66%
on 05/29/26
+25.55 (+16.31%)
since 04/29/26
3-Month
154.50 +17.94%
on 04/30/26
185.28 -1.66%
on 05/29/26
+3.40 (+1.90%)
since 02/27/26
52-Week
136.41 +33.58%
on 06/03/25
247.04 -26.24%
on 01/09/26
+43.43 (+31.29%)
since 05/28/25

Most Recent Stories

More News
IQVIA CEO to Speak at Jefferies Global Healthcare Conference

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, announced...

IQV : 182.21 (+0.62%)
Are Wall Street Analysts Predicting IQVIA Holdings Stock Will Climb or Sink?

While IQVIA Holdings has lagged behind the SPX over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

XLV : 149.47 (-0.93%)
$SPX : 7,580.06 (+0.22%)
IQV : 182.21 (+0.62%)
1 Mid-Cap Stock Worth Your Attention and 2 We Question

1 Mid-Cap Stock Worth Your Attention and 2 We Question

FCNCA : 199.05 (-90.09%)
LDOS : 127.80 (-2.88%)
IQV : 182.21 (+0.62%)
IQVIA and Kexing Biopharm Expand Strategic Collaboration to Accelerate Global Biosimilar Development using AI-Enabled Capabilities

IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, is advancing its strategic collaboration...

IQV : 182.21 (+0.62%)
Repligen, AdaptHealth, and IQVIA Stocks Trade Down, What You Need To Know

Repligen, AdaptHealth, and IQVIA Stocks Trade Down, What You Need To Know

RGEN : 123.95 (+0.99%)
AHCO : 10.13 (-2.13%)
IQV : 182.21 (+0.62%)
IQVIA’s Q1 Earnings Call: Our Top 5 Analyst Questions

IQVIA’s Q1 Earnings Call: Our Top 5 Analyst Questions

IQV : 182.21 (+0.62%)
IQVIA Q1 Earnings Call Highlights

IQVIA (NYSE:IQV) reported record first-quarter revenue and adjusted diluted earnings per share for 2026, with management citing accelerating organic growth across its Commercial Solutions and R&D Solutions...

IQV : 182.21 (+0.62%)
IQVIA Board of Directors Approves $2 Billion Increase in Share Repurchase Authorization

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, announced...

IQV : 182.21 (+0.62%)
IQVIA CFO to Speak at Bank of America Health Care Conference 2026

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, announced...

IQV : 182.21 (+0.62%)
Stocks making big moves yesterday: Cogent, AdaptHealth, BWX, IQVIA, and Palantir Technologies

Stocks making big moves yesterday: Cogent, AdaptHealth, BWX, IQVIA, and Palantir Technologies

CCOI : 17.76 (-10.39%)
AHCO : 10.13 (-2.13%)
BWXT : 195.88 (-1.70%)
PLTR : 156.54 (+9.21%)
IQV : 182.21 (+0.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

IQVIA Holdings Inc. provides advanced analytics, technology solutions and contract research services to the life sciences industry. The company was formed through the merger of IMS Health (RX) and Quintiles. The company is focused on helping healthcare clients to better serve patients by bringing in...

See More

Key Turning Points

3rd Resistance Point 192.39
2nd Resistance Point 188.84
1st Resistance Point 185.52
Last Price 182.21
1st Support Level 178.65
2nd Support Level 175.10
3rd Support Level 171.78

See More

52-Week High 247.04
Fibonacci 61.8% 204.78
Fibonacci 50% 191.73
Last Price 182.21
Fibonacci 38.2% 178.67
52-Week Low 136.41

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.